382 related articles for article (PubMed ID: 25773908)
21. TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells.
Zheng B; Ohuchida K; Cui L; Zhao M; Shindo K; Fujiwara K; Manabe T; Torata N; Moriyama T; Miyasaka Y; Ohtsuka T; Takahata S; Mizumoto K; Oda Y; Tanaka M
Int J Oncol; 2015 Aug; 47(2):490-8. PubMed ID: 26035794
[TBL] [Abstract][Full Text] [Related]
22. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
[TBL] [Abstract][Full Text] [Related]
23. E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.
Stark AP; Chang HH; Jung X; Moro A; Hertzer K; Xu M; Schmidt A; Hines OJ; Eibl G
Surgery; 2015 Dec; 158(6):1564-72. PubMed ID: 26297056
[TBL] [Abstract][Full Text] [Related]
24. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions.
Ouyang H; Gore J; Deitz S; Korc M
Oncogene; 2014 Sep; 33(38):4664-74. PubMed ID: 24096486
[TBL] [Abstract][Full Text] [Related]
25. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract][Full Text] [Related]
26. Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1/9.
Wang H; Li QF; Chow HY; Choi SC; Leung YC
J Physiol Biochem; 2020 Feb; 76(1):73-83. PubMed ID: 31823303
[TBL] [Abstract][Full Text] [Related]
27. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
28. SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.
Nishioka R; Itoh S; Gui T; Gai Z; Oikawa K; Kawai M; Tani M; Yamaue H; Muragaki Y
Exp Mol Pathol; 2010 Oct; 89(2):149-57. PubMed ID: 20576520
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition.
Xiong C; Zhu Y; Xue M; Jiang Y; Zhong Y; Jiang L; Shi M; Chen H
Aging (Albany NY); 2021 Jan; 13(3):3386-3404. PubMed ID: 33428605
[TBL] [Abstract][Full Text] [Related]
30. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
[TBL] [Abstract][Full Text] [Related]
31. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L
Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512
[TBL] [Abstract][Full Text] [Related]
32. The basic helix-loop-helix transcription factor DEC2 inhibits TGF-β-induced tumor progression in human pancreatic cancer BxPC-3 cells.
Sato F; Kawamura H; Wu Y; Sato H; Jin D; Bhawal UK; Kawamoto T; Fujimoto K; Noshiro M; Seino H; Morohashi S; Kato Y; Kijima H
Int J Mol Med; 2012 Sep; 30(3):495-501. PubMed ID: 22735690
[TBL] [Abstract][Full Text] [Related]
33. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
34. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
[TBL] [Abstract][Full Text] [Related]
35. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
[TBL] [Abstract][Full Text] [Related]
36. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
Jungert K; Buck A; von Wichert G; Adler G; König A; Buchholz M; Gress TM; Ellenrieder V
Cancer Res; 2007 Feb; 67(4):1563-70. PubMed ID: 17308095
[TBL] [Abstract][Full Text] [Related]
37. Embigin, regulated by HOXC8, plays a suppressive role in breast tumorigenesis.
Chao F; Zhang J; Zhang Y; Liu H; Yang C; Wang J; Guo Y; Wen X; Zhang K; Huang B; Liu D; Li Y
Oncotarget; 2015 Sep; 6(27):23496-509. PubMed ID: 26090721
[TBL] [Abstract][Full Text] [Related]
38. The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer.
Wu Y; Sato F; Yamada T; Bhawal UK; Kawamoto T; Fujimoto K; Noshiro M; Seino H; Morohashi S; Hakamada K; Abiko Y; Kato Y; Kijima H
Int J Oncol; 2012 Oct; 41(4):1337-46. PubMed ID: 22825629
[TBL] [Abstract][Full Text] [Related]
39. The potential role of the glycoprotein osteoactivin/glycoprotein nonmetastatic melanoma protein B in pancreatic cancer.
Torres C; Linares A; Alejandre MJ; Palomino-Morales R; Martin M; Delgado JR; Martinez J; Perales S
Pancreas; 2015 Mar; 44(2):302-10. PubMed ID: 25426614
[TBL] [Abstract][Full Text] [Related]
40. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
Kim YS; Choi KC; Hwang KA
Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
